LACTOTRANSFERRIN AND MIF PROMOTER POLYMORHPISM DETECTION FOR CANCER DETECTION AND TREATMENT

摘要

Provided herein are compositions, systems, kits, and methods for performing an activity based on detecting, in a sample from a cancer patient, the presence of elevated levels of Lactotransferrin (LTF) mRNA or protein, or detecting the presence in the MIF promoter region of at least one of: -173C and -794 CATT5-8, and treating a patient with immunotherapy, or generating a report that the subject should be treated with immunotherapy.